Horizon Therapeutics gets good news for flagship drug while advancing MoCo R&D hub, Amgen deal


The company is among multiple biotechs to make big moves in the D.C. area in recent days.

Previous Temple University Health System CFO leaving for new job
Next New dean talks vision for UAB Marnix E. Heersink School of Medicine